These approvals subsequently triggered intense pharmaceutical research, leading to the numerous options available ... aiding in the development of more reliable treatment algorithms.

From disease-modifying medications to rehabilitation strategies, choosing treatment for multiple sclerosis starts with understanding your options. Take an active role in managing your care. Verywell ...

Treatment can make living with multiple sclerosis (MS) easier. Some drugs (called “disease-modifying”) make it less likely that a patient will have a future MS attack or develop new lesions. In some ...

While there’s no cure for multiple sclerosis (MS), there are many treatments available. These treatments mainly focus on slowing down the progression of the disease and managing symptoms.

Our providers work together. They understand the full range of treatment options, so they can tailor a care plan to your exact needs. There is no single test for multiple sclerosis. Experts diagnose ...

Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. Autologous ...

There are a few types of MS. Knowing which type you have can help predict disease severity and how well treatment will work. Most people with multiple sclerosis (MS) have a type called relapsing ...

1 Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Cardiff, UK Background A minority of patients with multiple sclerosis (MS) have ...

Multiple sclerosis is rarely fatal. Some people with this disease may have a lifespan that’s slightly shorter than average, but it’s increased over time due to better treatments. Most people with ...

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying ...

Multiple sclerosis (MS ... routine MRI scans for people with multiple sclerosis. Ultimately, the goal is to help clinicians predict the likelihood of a patient developing new lesions and needing an ...